While apoliprotein E (ApoE) c4 allele is now a well established risk factor for familial and sporadic senile Alzheimer's disease (AD), its role in the development of the rarer presenile or early onset type is controversial. Early studies showed no association; later ones found enrichment for the £4 allele in familial or sporadic types or both. We have ApoE genotyped a series of Scottish people (n = 85) with early onset AD. We find highly significant enrichment for both homozygote and heterozygote ApoE £4 allele carriers in familial and sporadic early onset AD with a pattern closely resembling that in late onset AD.
AD is a neurodegenerative disorder characterised by amyloid peptide deposits in senile plaques and cerebral blood vessel walls, and neurofibrillary tangles (NFTs) within neurones of the cerebral cortex and hippocampus. ApoE has been found localised to senile plaques, vascular amyloid, and NFTs" and one allele, £4, is significantly associated with familial and sporadic late onset AD. [2] [3] [4] [5] [6] [7] [8] ApoE is a 34 kDa protein that is involved in cholesterol and triglyceride transport, mediating their clearance from plasma by interaction with low density lipoprotein receptor. 9 Unlike other lipoproteins which are mainly synthesised in the liver, ApoE is also synthesised in astrocytes and oligodendrocytes in the central nervous system. 9 It has three isoforms corresponding to alleles £2, c3, and £4. The Table 2 gives ApoE A4 allele numbers and percentages in early onset AD and control groups, as well as separate figures for family history positive and negative cases. Highly significant (p<0-001) differences in A4 allele numbers were found when the early onset AD group as a whole was compared to the non-demented controls or the Scottish population (X2=21 6 and 72-3 respectively, 2 df). These differences remained highly significant when we analysed separately the family history positive (X2 = 13-1, and 39 4, 2 df) and family history negative cases subgroups (X2= 19-1 and 63-1, 2 df). Table 3 gives the ODDs ratios for early onset AD associated with the ApoE A4 allele. The genotype frequencies of controls are estimated from population allele frequencies under Hardy-Weinberg assumptions. The risk of early onset AD is 4-6 times higher for carriers of at least one ApoE A4 allele compared to subjects without an ApoE IA allele. The greatest increase is in those with a family history, but does not differ significantly from those without a family history. It is also increased more than four-fold in homozygous IA carriers compared to heterozygous carriers. 
